Transcription factor e2f dna-binding domain inhibitor...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 7/06 (2006.01) A61K 38/08 (2006.01) A61K 38/10 (2006.01) C07K 7/08 (2006.01) C07K 14/47 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2359043

The present invention provides peptides which bind to the DNA binding domain of transcription factor E2F, and inhibit cell cycle progression. Peptides include FWLRFT (SEQ ID NO:1); WVRWHF (SEQ ID NO:2); WHFIFW (SEQ ID NO:3); IWLSGLSRGVWVSFP (SEQ ID NO:4); and GSRILTFRSGSWYAS (SEQ ID NO:5) and derivatives based upon these sequences. Compositions and the use of the peptides in inhibiting cell cycle progression, such as in uncontrolled cell proliferation, are also provided.

La présente invention concerne des peptides qui se lient au domaine liant l'ADN du facteur de transcription et inhibent la progression du cycle cellulaire. Ces peptides comprennent FWLRFT (SEQ ID NO:1); WVRWHF (SEQ ID NO:2); WHFIFW (SEQ ID NO:3); IWLSGLSRGVWVSFP (SEQ ID NO:4); et GSRILTFRSGSWYAS (SEQ ID NO:5) ainsi que les dérivés fondés sur ces séquences. L'invention concerne aussi des compositions et l'utilisation des peptides dans l'inhibition de la progression du cycle cellulaire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Transcription factor e2f dna-binding domain inhibitor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transcription factor e2f dna-binding domain inhibitor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transcription factor e2f dna-binding domain inhibitor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1662798

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.